Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Join us on Tuesday 4 June for an exclusive drinks reception and panel event featuring some of the UK’s top former and current sports professionals living with type 1 diabetes.
Find out about the latest progress in type 1 diabetes research, learn more about our ongoing partnerships or see what our celebrity ambassadors are up to.
Join the type 1 diabetes community and come together, raising awareness and vital funds for T1D. Every pound raised directly supports us to fund our life-changing research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > News & events > News > New autoimmune research charity joins the Connect Immune Research partnership
Juvenile Arthritis Research, a charity focused on the autoimmune condition juvenile idiopathic arthritis (JIA), becomes the 12th member of the Connect Immune Research partnership.
Established in 2018, Connect Immune Research is a collaborative initiative that aims to unpick the root causes of autoimmunity, where the immune system mistakenly attacks our own healthy cells. The partnership enables scientists to think beyond individual autoimmune conditions and explore overlapping causes of autoimmunity. This tactic boosts our potential of developing new treatments for a range of conditions including type 1 diabetes, multiple sclerosis and arthritis.
JIA is a rheumatic condition – meaning chronic joint pain – that begins before children are 16 years old. It happens when the immune system attacks and damages the joints, resulting in pain and mobility issues. Although JIA begins in childhood and adolescence, it is a lifelong condition. We have immune therapies that can target the symptoms of JIA, but not the underlying causes. Juvenile Arthritis Research is a parent-led charity committed to finding a cure for JIA.
Richard Beesley, Founder of Juvenile Arthritis Research, said: “When I first founded Juvenile Arthritis Research five years ago it was with the expectation that some of the clues to better understanding Juvenile Idiopathic Arthritis, and some of the knowledge to develop better treatments, would be by working closely with other autoimmune disease areas. That’s why I am delighted that we are joining the Connect Immune Research partnership, with the aim to continue to transform lives through working with others, sharing knowledge and ideas, and making a better future for the children, young people, adults and families we support.”
Dr Caroline Schmutz, Head of Research Partnerships at JDRF UK, said: “We are excited to welcome Juvenile Arthritis Research as our newest Connect Immune Research member. Their collaborative approach to research and confidence in the benefits of combining research across different disease areas make Juvenile Arthritis Research an ideal partner. The more research organisations we have studying the biological mechanisms driving autoimmunity, the sooner we will develop new treatments and cures for multiple autoimmune conditions.”
Find out more about our Connect Immune Research partnership.
Learn about British Thyroid Foundation (BTF) joining Connect Immune Research.
Learn about Professor Lucy Walker's research project, funded through Connect Immune Research.
A new paper co-authored by Breakthrough T1D, Diabetes UK, and Kidney Research UK has identified six themes to tackle diabetic kidney disease.
Our highlights from a year full of breakthroughs in type 1 diabetes research and advocacy.
The framework aims to encourage UK researchers to consider different sexes (biological attributes) and genders (roles, behaviours and identity in society) to address gaps in health data.
Our Access for All report, launched today, highlights how far we’ve come with advancements in diabetes technology, but shows that many people still face barriers when trying to access T1D technology.
Immunotherapy, beta cell replacement, smart insulins – we’re driving research in the most promising areas to find cures and better treatments for type 1 diabetes.
